Announcements Trials
Browse Landscape

Status

Completed 2

Sponsor Class

OTHER 23NETWORK 3OTHER_GOV 2

Study Type

Observational 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Stomach Neoplasms 2Hypertension 1Diabetes Mellitus 1

Interventions

Oxaliplatin 10Fluorouracil 6Irinotecan 5Docetaxel 5Capecitabine 5tislelizumab 4S 1 (combination) 4Paclitaxel 4Endoscopic Mucosal Resection 4XELOX 3Levoleucovorin 3Laparoscopy 3Folfox protocol 3sintilimab 2apatinib 2Proton Pump Inhibitors 2Gastroenterostomy 2Gastrectomy 2Clarithromycin 2Chemotherapy, Adjuvant 2Amoxicillin 2vactosertib 1titanium silicide 1pembrolizumab 1lenvatinib 1durvalumab 1bismuth tripotassium dicitrate 1anlotinib 1Trastuzumab 1Tranexamic Acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER_GOV × Stomach Neoplasms × Gastrectomy × Clear all
NCT05075421 2022-03-18

Prognostic Values of Inflammation-based Indices in Gastric Cancer

Gulhane Training and Research Hospital

Completed
350 enrolled
Gastrointestinal

Stomach Neoplasms

NCT01643811 2016-03-24

Effect of Gastrectomy and Anastomosis on Diabetes and Hypertension in Early Gastric Cancer Patients

National Cancer Center, Korea

Completed
159 enrolled
Gastrointestinal

Diabetes Mellitus, Hypertension, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡